Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks FDA Compliance for Peptide Therapy and BPC 157 Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr. and the Perils of Peptides Washington Monthly